600 mg eculizumab, givet som en intravenøs infusion af 25- 45 minutters varighed hver uge de første fire uger, efterfulgt af 900 mg eculizumab i startfasens femte uge.
600 mg of eculizumab via a 25 - 45 minute intravenous infusion every week for the first 4 weeks, followed by 900 mg of eculizumab for the fifth week of the initial phase.